Find an Article

Filter articles

Applied Filters

Showing 1 to 10 of 294 results

Microbial consortia: establishing a strong IP position in Europe

EU23-08-2022Ine Vanderleyden

Protecting new and inventive innovations in this increasingly crowded area is essential, explains Ine Vanderleyden of Mewburn Ellis.

The fall of COVID-19 and the rise of antimicrobial resistance

International17-03-2022Donald McNab and Mark Schuster

With evidence of antimicrobial resistance increasing, can innovation incentives drive pharma to fight back? Donald McNab and Mark Schuster of Marks & Clerk explore.

Will authorised biologics deter biosimilars? Utilising JFTC’s expertise in drug pricing

Japan08-03-2022Takanori Abe

Should the MHLW and CSIMC consider competition in drug pricing, it would be necessary to formulate systems to utilise the expertise of a competition expert, namely the Japan Fair Trade Commission, says Takanori Abe of Abe & Partners.

SurgiSil: Lip implant case shows looks can be deceiving

US03-03-2022Elizabeth Ferrill

A seemingly small decision by the US Court of Appeals for the Federal Circuit could have a big impact on owners of design patents, explains Elizabeth Ferrill of Finnegan.

When alliances fail, is arbitration the answer?


The global pandemic has increased collaboration and a new wave of disputes is likely. Arbitration is well placed to help, argue Kate Davies McGill, Gaela Gehring Flores and Paul Keller of Allen & Overy

UN International Day of Women and Girls in Science: a perspective

International10-02-2022Chiara Banas

Chiara Banas, patent scientist at EIP, queries the gender gap in life sciences, and shares how her own experiences could prefigure change.

Pandemic blues: the global approach to COVID-related IP

US20-01-2022Matthew Howell and Lauren Griffin

While the effort to secure greater vaccine and treatment equality via an IP waiver is admirable, it could stifle innovation and create long-term problems, say Matthew Howell and Lauren Griffin of Alston & Bird.

Amendments to Chinese Patents Law for the Life Sciences

China09-09-2021Keith Haddaway and Christopher Loh

Recent changes to patent law in China sees registration, review and litigation fall in line with established international IP systems, say Venable partners Keith Haddaway and Christopher Loh.

Conference preview: ACI breaks down Section 337 at the 13th Annual Practitioners’ Think Tank

International23-06-2021The C5 Group (American Conference Institute, The Canadian Institute, C5)

Making sense of the newest Section 337 developments will be a key focus of The American Conference Institute’s 13th Annual Practitioners’ Think Tank on ITC Litigation and Enforcement.

Navigating patent eligibility in digital healthcare

US22-06-2021Linda Thayer, Aaron Capron and Sneha Nyshadham

Patent applicants with digital health inventions need to remember that being useful and novel may not be enough, warn Linda Thayer, Aaron Capron and Sneha Nyshadham of Finnegan, Henderson, Farabow, Garrett & Dunner.

Showing 1 to 10 of 294 results